Reassessing the Role of Morning Cortisol in Adrenal Insufficiency Diagnosis: Insights from a Multicentric Cohort

Abstract

The diagnosis of adrenal insufficiency (AI) is challenging due to nonspecific symptoms. Measuring 8 AM serum cortisol levels is a common screening test, but its accuracy in predicting AI remains uncertain. This study aimed to evaluate the predictive diagnostic value of basal morning cortisol levels in suspected AI cases and compare them with levels in healthy individuals. We have conducted a retrospective multicentric cohort study. The study included an epidemiological cohort (patients with AI suspicion) and a control cohort (healthy volunteers). In the epidemiological cohort an ACTH-stimulation test was performed to confirm (AI group) or exclude (non-AI group) the disease. We have included 273 individuals (168 suspected AI cases and 105 controls). Basal cortisol levels were higher in the control group compared to the AI-suspected group (9.9±3.2 μg/dl vs. 7.7±3.3 μg/dl, p<0.001), though both were below the 15 μg/dl recommended threshold for excluding AI. Within the epidemiological cohort, even after a propensity score matching, taking into consideration sex, age and AI symptoms complaints, no significant difference in basal cortisol levels was found between patients with and without AI [6.10 (4.43; 8.45) vs. 7.14 (4.68; 12.15), p=0.128]. Logistic regression and ROC curve analyses showed a low predictive value for basal cortisol, with a positive predictive value of 18.9% and low specificity. AI patients more frequently experienced hypotension and nausea, compared with non-AI patients. Morning cortisol levels alone are unreliable for diagnosing AI. Revising cortisol cutoffs and incorporating symptom-based criteria may improve diagnostic accuracy.

Keywords

adrenal insufficiency - 8 a.m. serum cortisol - ACTH-stimulation test

Publication History

Received: 05 October 2024

Accepted after revision: 28 December 2024

Article published online:
23 January 2025

• References

• 1 Bornstein SR, Allolio B, Arlt W. et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 364-389
• 2 Fleseriu M, Hashim IA, Karavitaki N. et al. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 3888-3921
• 3 Grossman AB. The diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metab 2010; 95: 4855-4863
• 4 Santhanam P, Saleem SF, Saleem TF. Diagnostic predicament of secondary adrenal insufficiency. Endocr Pract 2010; 16: 686-691
• 5 Gruber LM, Bancos I. Secondary adrenal insufficiency: recent updates and new directions for diagnosis and management. Endocr Pract 2022; 28: 110-117
• 6 Bancos I, Hahner S, Tomlinson J. et al. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol 2015; 3: 216-226
• 7 de Miguel Novoa P, Vela ET, García NP. et al. Guidelines for the diagnosis and treatment of adrenal insufficiency in the adult. Endocrinol Nutr 2014; 61: 1-35
• 8 Vilar L. Endocrinologia clínica. Endocrinol Clín. 2006 3. 988
• 9 Badiu C, Md P. Williams textbook of endocrinology. Acta Endocrinol (Buchar) 2019; 15: 416
• 10 Gasco V, Bima C, Geranzani A. et al. Morning serum cortisol level predicts central adrenal insufficiency diagnosed by insulin tolerance test. Neuroendocrinology 2021; 111: 1238-1248
• 11 Butt MI, Alzuhayri N, Amer L. et al. Comparing the utility of 30- and 60-minute cortisol levels after the standard short synacthen test to determine adrenal insufficiency: a retrospective cross-sectional study. Medicine (Baltimore) 2020; 99: e22621
• 12 Druce MR, Akker SA, Chew SL. et al. Morbidity in patients on long-term steroid replacement therapy. Clin Endocrinol (Oxf) 2010; 72: 564-566
• 13 Gunnarsson C, Ryan MP, Marelli C. et al. Health care burden in patients with adrenal insufficiency. J Endocr Soc 2017; 1: 512-523
• 14 Reisch N, Arlt W. Fine tuning for quality of life: 21st century approach to treatment of Addison's disease. Endocrinol Metab Clin North Am 2009; 38: 407-418
• 15 Meyer G, Hackemann A, Penna-Martinez M. et al. What affects the quality of life in autoimmune Addison's disease?. Horm Metab Res 2013; 45: 92-95
• 16 Ravindran R, Carter JL, Kumar A. et al. Pre-test cortisol levels in predicting short Synacthen test outcome: a retrospective analysis. Clin Med Insights Endocrinol Diabetes 2022; 15 11795514221093316
• 17 Oboni JB, Marques-Vidal P, Pralong F. et al. Predictive factors of adrenal insufficiency in patients admitted to acute medical wards: a case control study. BMC Endocr Disord 2013; 13: 3
• 18 Kumar R, Carr P, Wassif W. Diagnostic performance of morning serum cortisol as an alternative to short synacthen test for the assessment of adrenal reserve; a retrospective study. Postgrad Med J 2022; 98: 113-118
• 19 Beuschlein F, Else T, Bancos I. et al. European society of endocrinology and endocrine society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. Eur J Clin Endocrinol 2024; 190: G25-G51
• 20 Mathara Diddhenipothage SAD, Beck KJ, Loo H. et al. “A morning cortisol is the most effective clinical predictor of short synacthen test outcome”: a tertiary care centre experience. Clin Endocrinol (Oxf) 2023; 99: 142-151
• 21 Ghasham AA, Radi S, Aljawi A. et al. Predictive value of different thresholds of morning cortisol in diagnosing adrenal insufficiency. Endocr Metab Sci 2024; 16: 100180
• 22 Agha A, Tomlinson JW, Clark PM. et al. The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 2006; 91: 43-47
• 23 Bangar V, Clayton RN. How reliable is the short synacthen test for the investigation of the hypothalamic-pituitary-adrenal axis?. Eur J Endocrinol 1998; 139: 580-583